Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Muriel Socquet"'
Autor:
Goran Stevanovic, Aleksandar Obradovic, Snezana Ristic, Dragan Petrovic, Branislava Milenkovic, Danilo Mitrovic, Svetlana Filipovic Vignjevic, Katarina Ilic, Vera Stoiljkovic, Lidija Lavadinovic, Mijomir Pelemis, Svetlana Petrovic, Ana Vidmanic, Olga Popovic, Natasa Eremic, Erin Sparrow, Guido Torelli, Muriel Socquet, Renée Holt, Yordanka Ilieva-Borisova, Yuxiao Tang, Francesco Berlanda Scorza, Jorge Flores, Niraj Rathi
Publikováno v:
Therapeutic Advances in Vaccines and Immunotherapy, Vol 8 (2020)
This study was a phase III, multicenter, double-blind, randomized, placebo-controlled trial to evaluate the safety and immunogenicity of a seasonal trivalent split, inactivated influenza vaccine (TIV) in healthy Serbian adults between the ages of 18
Externí odkaz:
https://doaj.org/article/1fb3d26d2cea44f3b3dcf12284b2c3bb
Autor:
Goran Stevanovic, Lidija Lavadinovic, Svetlana Filipovic Vignjevic, Renée Holt, Katarina Ilic, Francesco Berlanda Scorza, Erin Sparrow, Vera Stoiljkovic, Guido Torelli, Tamra Madenwald, Muriel Socquet, Aleksandra Barac, Yordanka Ilieva-Borisova, Mijomir Pelemis, Jorge Flores
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 14, Iss 3, Pp 579-586 (2018)
This study was a phase I double-blind, randomized, placebo-controlled trial to evaluate the safety and immunogenicity of a Serbian-produced seasonal trivalent split, inactivated influenza vaccine in healthy adults. The vaccine was manufactured in egg
Externí odkaz:
https://doaj.org/article/7fa15ca9a5884c72a51c286a6f94d75e
Autor:
Beatriz Thomé, Tazio Vanni, Alexander Roberto Precioso, Olga Menang, Muriel Socquet, Vera Lúcia Gattás, Mayra Martho Moura de Oliveira, Marcelo Eiji Koike, Maria Beatriz Bastos Lucchesi
Publikováno v:
Vaccine. 37:7560-7565
Instituto Butantan is a biomedical research center and vaccine manufacturer affiliated with the Sao Paulo State Secretary of Health in Brazil. In 2013, Instituto Butantan successfully licensed its trivalent influenza vaccine, in order to support the
Autor:
Tamra Madenwald, Vera Stoiljkovic, Francesco Berlanda Scorza, Guido Torelli, Jorge Flores, Svetlana Filipovic Vignjevic, Aleksandra Barac, Renee Holt, Katarina Ilic, Mijomir Pelemis, Lidija Lavadinovic, Goran Stevanovic, Erin Sparrow, Yordanka Ilieva-Borisova, Muriel Socquet
Publikováno v:
Human Vaccines & Immunotherapeutics
This study was a phase I double-blind, randomized, placebo-controlled trial to evaluate the safety and immunogenicity of a Serbian-produced seasonal trivalent split, inactivated influenza vaccine in healthy adults. The vaccine was manufactured in egg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7762a815bd1eb35da86e60113628771a
http://intor.torlakinstitut.com/bitstream/id/336/514.pdf
http://intor.torlakinstitut.com/bitstream/id/336/514.pdf
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
The Meningitis Vaccine Project (MVP), a partnership between PATH and the World Health Organization (WHO), was created in 2001 through core funding from the Bill & Melinda Gates Foundation to eliminate epidemic meningitis as a public health problem in
Autor:
F. Marc LaForce, Muriel Socquet, Cyrus Poonawalla, Prasad S. Kulkarni, Suresh Jadhav, Subhash V. Kapre
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Making and licensing a new vaccine is a complicated task, and new vaccine development has largely been the province of multinational companies often referred to as Pharma. This product development model is expensive and estimated to cost US$500–$75